{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T10:15:14Z","timestamp":1789467314679,"version":"build-2803163510"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T00:00:00Z","timestamp":1651104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To assess the characteristics and risk of lymphoma in a large cohort of patients with SLE.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A case\u2013cohort analysis was performed within a dynamic cohort of SLE patients from the Spanish Society of Rheumatology Lupus Registry (RELESSER). Clinical and analytical features were compared between the lymphoma SLE group and the control SLE group using an independent-sample Student\u2019s t-test or Mann\u2013Whitney test for continuous variables and the \u03c72 test for categorical variables with Fisher\u2019s exact test if necessary. The multivariate analysis was based on a generalized linear model.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Twenty-one patients with SLE and lymphoma and 3965 non-lymphoma controls with SLE were studied. Most lymphomas were of B cell origin (n\u2009=\u200915\/21), with diffuse large B cell lymphoma being the most frequent histological type (8\/21, 38.1%). As in the general population, the risk of lymphoma in SLE was higher in male than in female patients and increased with age. In the lymphoma SLE group, bivariate analysis showed a significantly higher percentage of pericarditis, organic brain syndrome, seizures, vasculitis, haemolytic anaemia, splenomegaly, venous thrombosis and mean modified (excluding lymphoma) SLICC\/ACR damage index. In contrast, renal involvement, positive anti-dsDNA, and antimalarials ever were less frequent.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>In this large multicentre Spanish cohort, we identified characteristics of SLE that are associated with a higher risk of lymphoma. Antimalarials were significantly negatively associated with risk of lymphoma in SLE patients. Nevertheless, further prospective studies are needed to clarify these findings.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keac258","type":"journal-article","created":{"date-parts":[[2022,4,24]],"date-time":"2022-04-24T11:06:54Z","timestamp":1650798414000},"page":"217-224","source":"Crossref","is-referenced-by-count":11,"title":["Clinical characteristics and risk factors associated with lymphoma in patients with systemic lupus erythematosus: a nationwide cohort study"],"prefix":"10.1093","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4218-5731","authenticated-orcid":false,"given":"Mar\u00eda","family":"Mart\u00edn-L\u00f3pez","sequence":"first","affiliation":[{"name":"Rheumatology Department, Hospital Universitario 12 de Octubre, Instituto de Investigaci\u00f3n Hospital 12 de Octubre (imas12) , Madrid"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Galindo","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Hospital Universitario 12 de Octubre, Instituto de Investigaci\u00f3n Hospital 12 de Octubre (imas12) , Madrid"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Mar\u00eda","family":"Pego-Reigosa","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Hospital do Meixoeiro , Vigo, Galicia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norman","family":"Jim\u00e9nez","sequence":"additional","affiliation":[{"name":"IRIDIS Group (Investigation in Rheumatology and Immune-Diseases), Galicia Sur Health Research Institute (IISGS) , Vigo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Oliv\u00e9 Marqu\u00e9s","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Hospital Universitario Germans Tr\u00edas i Pujol , Badalona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Tomero","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Hospital Universitario La Princesa , Madrid"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Freire","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Complejo Hospitalario Universitario A Coru\u00f1a , A Coru\u00f1a"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Mart\u00ednez-Barrio","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Hospital Universitario Gregorio Mara\u00f1\u00f3n"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Boteanu","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Hospital Universitario Ramon y Cajal , Madrid"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Salgado-Perez","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Complejo Hospitalario de Orense , Orense, Galicia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2962-9844","authenticated-orcid":false,"given":"Antonio","family":"Fern\u00e1ndez-Nebro","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Hospital Regional Universitario de M\u00e1laga , M\u00e1laga"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Calvo","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Hospital Universitario de Araba , Vitoria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul","family":"Menor-Almagro","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Hospital de Jerez , C\u00e1diz"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I\u00f1igo","family":"R\u00faa-Figueroa","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Hospital Universitario de Gran Canaria Dr Negrin , Las Palmas de Gran Canaria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,4,28]]},"reference":[{"key":"2022122410015499900_keac258-B1","first-page":"472","article-title":"Survival in adults and children with systemic lupus erythematosus: a systematic review and Bayesian meta-analysis of studies from 1950 to 2016","volume":"77","author":"Tektonidou","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2022122410015499900_keac258-B2","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.semarthrit.2011.11.002","article-title":"Global trend of survival and damage of systemic lupus erythematosus: meta-analysis and meta-regression of observational studies from the 1950s to 2000s","volume":"41","author":"Mak","year":"2012","journal-title":"Semin Arthritis Rheum"},{"key":"2022122410015499900_keac258-B3","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1177\/0961203313517015","article-title":"Trends in systemic lupus erythematosus mortality in Spain from 1981 to 2010","volume":"23","author":"Ruiz","year":"2014","journal-title":"Lupus"},{"key":"2022122410015499900_keac258-B4","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1002\/art.21955","article-title":"Mortality in systemic lupus erythematosus","volume":"54","author":"Bernatsky","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2022122410015499900_keac258-B5","first-page":"S72","article-title":"An update on mortality in systemic lupus erythematosus","volume":"26","author":"Ippolito","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"2022122410015499900_keac258-B6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1177\/0961203307077987","article-title":"Current causes of death in systemic lupus erythematosus in Europe, 2000\u20132004: relation to disease activity and damage accrual","volume":"16","author":"Nossent","year":"2007","journal-title":"Lupus"},{"key":"2022122410015499900_keac258-B7","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/01.bor.0000209423.39033.94","article-title":"Malignancy and autoimmunity","volume":"18","author":"Bernatsky","year":"2006","journal-title":"Curr Opin Rheumatol"},{"key":"2022122410015499900_keac258-B8","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/art.21029","article-title":"An international cohort study of cancer in systemic lupus erythematosus","volume":"52","author":"Bernatsky","year":"2005","journal-title":"Arthritis Rheum"},{"key":"2022122410015499900_keac258-B9","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/acr.24068","article-title":"Hormonal dependence and cancer in systemic lupus erythematosus","volume":"72","author":"Cobo-Ib\u00e1\u00f1ez","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2022122410015499900_keac258-B10","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.leukres.2014.06.025","article-title":"Systemic lupus erythematosus is associated with increased incidence of hematologic malignancies: a meta-analysis of prospective cohort studies","volume":"38","author":"Apor","year":"2014","journal-title":"Leukem Res"},{"key":"2022122410015499900_keac258-B11","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/s13075-018-1760-3","article-title":"The risks of cancer development in systemic lupus erythematosus (SLE) patients: a systematic review and meta-analysis","volume":"20","author":"Song","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"2022122410015499900_keac258-B12","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1191\/096120301678646128","article-title":"Systemic lupus erythematosus and the risk of malignancy","volume":"10","author":"Cibere","year":"2001","journal-title":"Lupus"},{"key":"2022122410015499900_keac258-B13","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1001\/archinte.165.20.2337","article-title":"The risk of lymphoma development in autoimmune diseases: a meta-analysis","volume":"165","author":"Zintzaras","year":"2005","journal-title":"Arch Intern Med"},{"key":"2022122410015499900_keac258-B14","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1365-2796.2008.02029.x","article-title":"Autoimmune and inflammatory disorders and risk of malignant lymphomas\u2014an update","volume":"264","author":"Smedby","year":"2008","journal-title":"J Intern Med"},{"key":"2022122410015499900_keac258-B15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/BOR.0000000000000026","article-title":"Incidence of lymphoma associated with underlying lupus: lessons learned from observational studies","volume":"26","author":"Bichile","year":"2014","journal-title":"Curr Opin Rheumatol"},{"key":"2022122410015499900_keac258-B16","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1158\/1055-9965.EPI-06-0300","article-title":"Malignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics","volume":"15","author":"Smedby","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2022122410015499900_keac258-B17","first-page":"217","article-title":"Increased risk of malignancy in patients with systemic lupus erythematosus","volume":"46","author":"Ramsey-Goldman","year":"1998","journal-title":"J Investig Med"},{"key":"2022122410015499900_keac258-B18","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1191\/096120301701548481","article-title":"Systemic lupus erythematosus and B-cell hematologic neoplasm","volume":"10","author":"Xu","year":"2001","journal-title":"Lupus"},{"key":"2022122410015499900_keac258-B19","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1136\/annrheumdis-2012-202099","article-title":"Lymphoma risk in systemic lupus: effects of disease activity versus treatment","volume":"73","author":"Bernatsky","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2022122410015499900_keac258-B20","first-page":"620","article-title":"Cumulative immunosuppressant exposure is associated with diversified cancer risk among 14 832 patients with systemic lupus erythematosus: a nested case\u2013control study","volume":"56","author":"Hsu","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"2022122410015499900_keac258-B21","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/ard.2006.069039","article-title":"The relationship between cancer and medication exposures in systemic lupus erythaematosus: a case-cohort study","volume":"67","author":"Bernatsky","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"2022122410015499900_keac258-B22","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"2022122410015499900_keac258-B23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.reuma.2013.04.013","article-title":"Registro nacional de pacientes con lupus eritematoso sist\u00e9mico de la Sociedad Espa\u00f1ola de Reumatolog\u00eda: objetivos y metodolog\u00eda","volume":"10","author":"R\u00faa-Figueroa","year":"2014","journal-title":"Reumatol Cl\u00edn"},{"key":"2022122410015499900_keac258-B24","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"2022122410015499900_keac258-B25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","article-title":"2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sj\u00f6gren's syndrome: a consensus and data-driven methodology involving three international patient cohorts","volume":"76","author":"Shiboski","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2022122410015499900_keac258-B26","author":"World Medical Association. WMA Declaration of Helsinki"},{"key":"2022122410015499900_keac258-B27","author":"Convenio para la protecci\u00f3n de los derechos humanos y la dignidad del ser humano con respecto a las aplicaciones de la biolog\u00eda y la medicina"},{"key":"2022122410015499900_keac258-B28","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/00002281-199609000-00007","article-title":"Prognosis and treatment of systemic lupus erythematosus","volume":"8","author":"Gladman","year":"1996","journal-title":"Curr Opin Rheumatol"},{"key":"2022122410015499900_keac258-B29","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1136\/ard.2006.067108","article-title":"A closer look at non-Hodgkin's lymphoma cases in a national Swedish systemic lupus erythematosus cohort: a nested case-control study","volume":"66","author":"Lofstrom","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"2022122410015499900_keac258-B30","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s10067-006-0532-7","article-title":"Characteristics of patients with systemic lupus erythematosus (SLE) and non-Hodgkin's lymphoma (NHL)","volume":"26","author":"King","year":"2007","journal-title":"Clin Rheumatol"},{"key":"2022122410015499900_keac258-B31","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/ejh.12116","article-title":"Methotrexate\/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression","volume":"91","author":"Ichikawa","year":"2013","journal-title":"Eur J Haematol"},{"key":"2022122410015499900_keac258-B32","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/ard.51.4.437","article-title":"Increased risk of cancer in patients with systemic lupus erythematosus","volume":"51","author":"Pettersson","year":"1992","journal-title":"Ann Rheum Dis"},{"key":"2022122410015499900_keac258-B33","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1080\/03009740252937568","article-title":"Increased cancer incidence in a Swedish cohort of patients with systemic lupus erythematosus","volume":"31","author":"Bj\u00f6rn\u00e5dal","year":"2002","journal-title":"Scand J Rheumatol"},{"key":"2022122410015499900_keac258-B34","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1093\/jnci\/djj361","article-title":"Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia","volume":"98","author":"Landgren","year":"2006","journal-title":"J Natl Cancer Inst"},{"issue":"Suppl 2","key":"2022122410015499900_keac258-B35","first-page":"A1729","article-title":"Patients with systemic lupus erythematosus and lymphoma at a tertiary hospital: descriptive analysis of nine patients","volume":"78","author":"Mart\u00edn-L\u00f3pez","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2022122410015499900_keac258-B36","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1136\/ard.2006.068676","article-title":"Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L)","volume":"66","author":"Alarc\u00f3n","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"2022122410015499900_keac258-B37","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1002\/art.34672","article-title":"Predictors of organ damage in systemic lupus erythematosus: the Hopkins Lupus Cohort","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2022122410015499900_keac258-B38","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s13075-020-02228-6","article-title":"The relationship between cancer and medication exposure in patients with systemic lupus erythematosus: a nested case-control study","volume":"22","author":"Guo","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"2022122410015499900_keac258-B39","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1136\/ard.2006.067777","article-title":"Antimalarials may influence the risk of malignancy in systemic lupus erythematosus","volume":"66","author":"Ruiz-Irastorza","year":"2007","journal-title":"Ann Rheum Dis"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keac258\/43722545\/keac258.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/1\/217\/48405969\/keac258.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/1\/217\/48405969\/keac258.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,24]],"date-time":"2022-12-24T10:02:55Z","timestamp":1671876175000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/62\/1\/217\/6575422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,28]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,4,28]]},"published-print":{"date-parts":[[2022,12,23]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keac258","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,1,1]]},"published":{"date-parts":[[2022,4,28]]}}}